Understanding VivaChek's Approach to Pet Health Monitoring
Veterinary professionals and pet owners managing animals with metabolic conditions require diagnostic tools that deliver accurate, reliable, and easy-to-use results without unnecessary complexity. This is the exact gap that VivaChek Biotech (Hangzhou) Co., Ltd. addresses through its diversified point-of-care testing (POCT) portfolio. Founded in August 2013 and headquartered in Hangzhou, Zhejiang, People's Republic of China, VivaChek has grown into a company whose products are now available in over 120 countries across the globe.
VivaChek operates with the development concept of "making health management accessible," building an ecosystem that combines "chronic disease management + rapid diagnosis + digital medical" while aiming to become a globally trusted smart POCT provider. This positioning is directly relevant to pet glucose monitoring, since diabetes and other metabolic conditions in animals demand the same kind of consistent, dependable testing that VivaChek has applied across its human diagnostic lines.
The Blood Glucose Monitoring System Within VivaChek's Veterinary Portfolio
Within its dedicated Veterinary product category, VivaChek offers a Blood Glucose Monitoring System designed specifically for veterinary settings. This system sits alongside other veterinary-focused tools in the same portfolio, including the Blood Ketone Monitoring System, the Milk Ketone Monitoring System, the Veterinary Coagulation and Chemistry Combo, and the Veterinary Coagulation and Chemistry Combo Analyzer. Positioned to meet the blood glucose monitoring needs of veterinary professionals, this system gives clinics and animal care providers a monitoring option that is part of a larger, integrated diagnostic ecosystem rather than a standalone device.
Because the Blood Glucose Monitoring System belongs to the same veterinary portfolio as coagulation, chemistry, and ketone testing tools, veterinary teams can rely on a single company for multiple aspects of animal metabolic and health assessment, rather than sourcing glucose testing separately from other diagnostic needs.
Biosensor Technology Supporting Metabolic Marker Detection
At the core of VivaChek's monitoring capability is its biosensor technology, which the company applies for glucose, ketone, and uric acid monitoring across its technology platform. This sensor-based approach is a foundational element of how VivaChek's monitoring systems detect and quantify metabolic markers, and it underpins the broader family of devices the company has developed for tracking these parameters. For veterinary applications, this same technological foundation supports the company's ability to extend glucose and ketone monitoring capabilities into animal health contexts, in addition to its human-focused blood glucose and multi-function monitoring systems.
Complementary Veterinary Diagnostic Technologies
Beyond glucose monitoring alone, VivaChek's veterinary lineup demonstrates a broader technical capability that reflects the depth of its diagnostic engineering. The Veterinary Coagulation and Chemistry Combo, for instance, runs on a centrifugal microfluidic platform and is built for rapid results: coagulation testing is completed in ≤15 minutes and chemistry testing in ≤13 minutes. Sample volume requirements are notably small — 140 μL for chemistry and 180 μL for coagulation — which is a meaningful consideration in veterinary practice where sample collection from animals can be more challenging than in human patients.
The system uses lyophilized reagent with a storage condition of 2-8 °C (35.6 °F - 46.4 °F) and a shelf life of 12 months, packaged as 1 test/pouch, 20 tests/kit or 10 tests/kit. This level of technical specificity across coagulation and chemistry testing indicates that VivaChek approaches veterinary diagnostics with the same rigor applied to its human diagnostic lines, rather than treating animal health testing as a secondary offering.
The inclusion of a dedicated Milk Ketone Monitoring System further shows that VivaChek's veterinary scope extends beyond companion animal care into dairy herd monitoring, reinforcing that its glucose and ketone monitoring technologies are part of a wider, purpose-built veterinary diagnostic strategy rather than a single-product afterthought.
Global Quality Standards Backing Every VivaChek Device
A key reason veterinary professionals and clinics can place confidence in VivaChek's monitoring systems is the company's alignment with recognized international quality frameworks. VivaChek's quality management system is aligned with FDA 510(k) clearance, European Union CE, China NMPA, EN ISO 13485, China GMP, the international ISO system, and FDA QSR (Quality System Regulations). For its human glucose meters — the VivaChek Ino and VivaChek Eco — the company also maintains compliance with DIN EN ISO 15197:2013, illustrating the accuracy standards the company applies to its glucose testing technology more broadly.
This regulatory alignment is supported by a genuinely global operational footprint. VivaChek's headquarters is located in Hangzhou, Zhejiang, with a manufacturing facility in Shaoxing, Zhejiang Province. The company also operates through Vivachek Diagnostics Inc. in Sacramento, California, VivaChek Laboratoires, Inc. in Wilmington, Delaware, VivaChek Life Care in Chennai, India, and dedicated Singapore and India branches. This international presence has enabled VivaChek products to reach diabetic patients and diagnostic users in more than 30 countries within the first year after launch, eventually expanding to the current footprint of over 120 countries.
Why Veterinary Professionals and Pet Owners Consider VivaChek
For anyone evaluating a glucose monitor for pet care, several factors from VivaChek's documented portfolio stand out. First, the Blood Glucose Monitoring System is not an isolated product but part of a structured veterinary diagnostic ecosystem that also covers ketone and milk ketone monitoring, plus coagulation and chemistry testing — giving veterinary practices a consolidated diagnostic partner. Second, the underlying biosensor technology applied for glucose, ketone, and uric acid detection reflects a consistent technological approach the company has refined across its broader monitoring systems, including devices with optional Bluetooth data transfer for digital connectivity in select systems. Third, the company's adherence to multiple international quality certifications — spanning FDA, CE, NMPA, and ISO frameworks — provides a documented quality foundation across its diagnostic product lines.
Finally, VivaChek's scale of distribution, with products available in over 120 countries and glucose meters that have supported millions of diabetic patients worldwide, demonstrates the kind of established manufacturing and distribution infrastructure that underlies its veterinary offerings as well. Veterinary clinics and pet health professionals exploring a glucose monitor for pet care can look to VivaChek's veterinary portfolio as a solution built on the same technological foundation, regulatory rigor, and global reach that define the company's broader diagnostic ecosystem — one designed around the principle of "making health management accessible" for both humans and animals alike.
https://www.vivachek.com/veterinarytest.html
VivaChek Biotech (Hangzhou) Co., Ltd.
About Author
